Shopping Cart
Remove All
Your shopping cart is currently empty
VEGFR-2-IN-23 (compound 11b) is a highly potent and selective inhibitor of VEGFR-2, with an IC50 value of 0.34 nM. It demonstrates significant antitumor activity by inducing apoptosis and causing cell cycle arrest at the G1 phase [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | VEGFR-2-IN-23 (compound 11b) is a highly potent and selective inhibitor of VEGFR-2, with an IC50 value of 0.34 nM. It demonstrates significant antitumor activity by inducing apoptosis and causing cell cycle arrest at the G1 phase [1]. |
| Targets&IC50 | VEGFR2:0.19 nM |
| In vitro | VEGFR-2-IN-23 (compound 11b) exhibits antitumor activity with IC50 values of 23 nM, 0.8 nM, 1.3 nM, and 46 nM against PC3, DU145, MCF-7, and MDA-MB435 cancer cell lines, respectively [1]. |
| In vivo | VEGFR-2-IN-23, administered intraperitoneally at doses of 5 and 10 mg/kg, effectively suppresses tumor growth in MCF-7 xenograft models [1]. |
| Molecular Weight | 381.39 |
| Formula | C22H15N5O2 |
| Cas No. | 2411174-53-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.